The effect of amifostine or IMRT to preserve the parotid function after radiotherapy of the head and neck region measured by quantitative salivary gland scintigraphy

Radiotherapy and Oncology

Volumn 89, Issue 1, 2008, Pages 71-80

  Rudat, Volker ^a,b   Münter, Mark ^c   Rades, Dirk ^a,d   Grötz, Knut A ^e   Bajrovic, Amira ^a   Haberkorn, Uwe ^c   Brenner, Winfried ^a   Debus, Jürgen ^c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Amifostine; Head and neck cancer; IMRT; Salivary glands; Xerostomia

Indexed keywords

AMIFOSTINE;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; PAROTID GLAND; POST HOC ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; SALIVARY GLAND; SCINTIGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMIFOSTINE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAROTID GLAND; RADIATION DOSAGE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; XEROSTOMIA;

EID: 53049098704     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.07.016     Document Type: Article

References (41)

1. Mossman K., Shatzman A., and Chencharick J. Long-term effects of radiotherapy on taste and salivary function in man. Int J Radiat Oncol Biol Phys 8 (1982) 991-997
2. Jensen A.B., Hansen O., Jorgensen K., and Bastholt L. Influence of late side-effects upon daily life after radiotherapy for laryngeal and pharyngeal cancer. Acta Oncol 33 (1994) 487-491
3. Cooper J.S., Fu K., Marks J., and Silverman S. Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 31 (1995) 1141-1164
4. Bjordal K., Kaasa S., and Mastekaasa A. Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28 (1994) 847-856
5. Jellema A.P., Slotman B.J., Doornaert P., Leemans C.R., and Langendijk J.A. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 69 (2007) 751-760
6. Dawes C. Circadian rhythms in the flow rate and composition of unstimulated and stimulated human submandibular saliva. J Physiol 244 (1975) 535-548
7. Roh J.L., Kim A.Y., and Cho M.J. Xerostomia following radiotherapy of the head and neck affects vocal function. J Clin Oncol 23 (2005) 3016-3023
8. Jham B.C., Reis P.M., Miranda E.L., et al. Oral health status of 207 head and neck cancer patients before, during and after radiotherapy. Clin Oral Investig (2007)
9. Ohrn K.E., Wahlin Y.B., and Sjoden P.O. Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer 9 (2001) 247-257
10. Kielbassa A.M., Hinkelbein W., Hellwig E., and Meyer-Luckel H. Radiation-related damage to dentition. Lancet Oncol 7 (2006) 326-335
11. Balogh J.M., and Sutherland S.E. Osteoradionecrosis of the mandible: a review. J Otolaryngol 18 (1989) 245-250
12. Eisbruch A., Rhodus N., Rosenthal D., et al. The prevention and treatment of radiotherapy-induced xerostomia. Semin Radiat Oncol 13 (2003) 302-308
13. Bussels B., Maes A., Hermans R., Nuyts S., Weltens C., and Van den Bogaert W. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer. Radiother Oncol 72 (2004) 119-127
14. Munter M.W., Karger C.P., Hoffner S.G., et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy. Int J Radiat Oncol Biol Phys 58 (2004) 175-184
15. Chao K.S., Ozyigit G., Tran B.N., Cengiz M., Dempsey J.F., and Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
16. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
17. Brizel D.M., Wasserman T.H., Henke M., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 18 (2000) 3339-3345
18. Wasserman T., Mackowiak J.I., Brizel D.M., et al. Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer. Int J Radiat Oncol Biol Phys 48 (2000) 1035-1039
19. Eisbruch A., Rhodus N., Rosenthal D., et al. How should we measure and report radiotherapy-induced xerostomia?. Semin Radiat Oncol 13 (2003) 226-234
20. Rades D., Fehlauer F., Bajrovic A., Mahlmann B., Richter E., and Alberti W. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol 70 (2004) 261-264
21. Munter M.W., Debus J., Hof H., et al. Inverse treatment planning and stereotactic intensity-modulated radiation therapy (IMRT) of the tumor and lymph node levels for nasopharyngeal carcinomas. Description of treatment technique, plan comparison, and case study. Strahlenther Onkol 178 (2002) 517-523
22. Rades D., Fehlauer F., Wroblesky J., Albers D., Schild S.E., and Schmidt R. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy. Oral Oncol (2006)
23. Bohuslavizki K.H., Brenner W., Lassmann S., et al. Quantitative salivary gland scintigraphy - a recommended examination prior to and after radioiodine therapy. Nuklearmedizin 36 (1997) 103-109
24. Karger C.P., and Hartmann G.H. Determination of tolerance dose uncertainties and optimal design of dose-response experiments with small animal numbers. Strahlenther Onkol 177 (2001) 37-42
25. Munter M.W., Hoffner S., Hof H., et al. Changes in salivary gland function after radiotherapy of head and neck tumors measured by quantitative pertechnetate scintigraphy: comparison of intensity-modulated radiotherapy and conventional radiation therapy with and without Amifostine. Int J Radiat Oncol Biol Phys 67 (2007) 651-659
26. Roesink J.M., Moerland M.A., Hoekstra A., Van Rijk P.P., and Terhaard C.H. Scintigraphic assessment of early and late parotid gland function after radiotherapy for head-and-neck cancer: a prospective study of dose-volume response relationships. Int J Radiat Oncol Biol Phys 58 (2004) 1451-1460
27. Maes A., Weltens C., Flamen P., et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol 63 (2002) 203-211
28. Kaneko M., Shirato H., Nishioka T., et al. Scintigraphic evaluation of long-term salivary function after bilateral whole parotid gland irradiation in radiotherapy for head and neck tumour. Oral Oncol 34 (1998) 140-146
29. Hsiung C.Y., Ting H.M., Huang H.Y., Lee C.H., Huang E.Y., and Hsu H.C. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 454-461
30. Jellema A.P., Slotman B.J., Muller M.J., et al. Radiotherapy alone, versus radiotherapy with amifostine 3 times weekly, versus radiotherapy with amifostine 5 times weekly: a prospective randomized study in squamous cell head and neck cancer. Cancer 107 (2006) 544-553
31. Pacholke H.D., Amdur R.J., Morris C.G., et al. Late xerostomia after intensity-modulated radiation therapy versus conventional radiotherapy. Am J Clin Oncol 28 (2005) 351-358
32. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
33. Lin A., Kim H.M., Terrell J.E., Dawson L.A., Ship J.A., and Eisbruch A. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 57 (2003) 61-70
34. Jabbari S., Kim H.M., Feng M., et al. Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report. Int J Radiat Oncol Biol Phys 63 (2005) 725-731
35. Fang F.M., Tsai W.L., Chen H.C., et al. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques. Cancer 109 (2007) 313-321
36. Yao M., Karnell L.H., Funk G.F., Lu H., Dornfeld K., and Buatti J.M. Health-related quality-of-life outcomes following IMRT versus conventional radiotherapy for oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2007)
37. Graff P., Lapeyre M., Desandes E., et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 67 (2007) 1309-1317
38. Parliament M.B., Scrimger R.A., Anderson S.G., et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head-and-neck cancer. Int J Radiat Oncol Biol Phys 58 (2004) 663-673
39. Pow E.H., Kwong D.L., McMillan A.S., et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: Initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 66 (2006) 981-991
40. Grotz K.A., Wustenberg P., Kohnen R., et al. Prophylaxis of radiogenic sialadenitis and mucositis by coumarin/troxerutine in patients with head and neck cancer - a prospective,randomized, placebo-controlled, double-blind study. Br J Oral Maxillofac Surg 39 (2001) 34-39
41. Al-Nawas B., Al-Nawas K., Kunkel M., and Grotz K.A. Quantifying radioxerostomia: salivary flow rate, examiner's score, and quality of life questionnaire. Strahlenther Onkol 182 (2006) 336-341